Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eirini D Tseligka

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Viruses|April 30, 2021
HDV Pathogenesis: Unravelling Ariadne's ThreadEirini D Tseligka, Sophie Clément, Francesco Negro
Viruses|July 4, 2019
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?Valeria Cagno, Eirini D Tseligka, Samuel T Jones, et al.
JHEP Reports : Innovation in Hepatology|January 27, 2023
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule librariesEirini D Tseligka, Stéphanie Conzelmann, Yves Cambet, et al.
Molecular Pharmaceutics|May 13, 2016
Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled BisphosphonatesGeorge Makris, Eirini D Tseligka, Ioannis Pirmettis, et al.
Antiviral Research|June 12, 2018
Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium modelBernadett Boda, Sacha Benaoudia, Song Huang, et al.
Pharmaceutical Research|April 27, 2016
Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer TherapyEirini D Tseligka, Aikaterini Rova, Elsa P Amanatiadou, et al.
Plos Pathogens|August 4, 2018
A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropismEirini D Tseligka, Komla Sobo, Luc Stoppini, et al.
Cell Reports|April 14, 2023
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted miceKuo-Feng Weng, Han Kang Tee, Eirini D Tseligka, et al.
Scientific Reports|May 15, 2023
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistanceDiana Gomes, Cyril Sobolewski, Stéphanie Conzelmann, et al.
International Journal of Pharmaceutics|May 29, 2016
Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriersMaria Filippousi, Stuart Turner, Karen Leus, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Viruses|April 30, 2021
HDV Pathogenesis: Unravelling Ariadne's ThreadEirini D Tseligka, Sophie Clément, Francesco Negro
Viruses|July 4, 2019
Heparan Sulfate Proteoglycans and Viral Attachment: True Receptors or Adaptation Bias?Valeria Cagno, Eirini D Tseligka, Samuel T Jones, et al.
JHEP Reports : Innovation in Hepatology|January 27, 2023
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule librariesEirini D Tseligka, Stéphanie Conzelmann, Yves Cambet, et al.
Molecular Pharmaceutics|May 13, 2016
Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled BisphosphonatesGeorge Makris, Eirini D Tseligka, Ioannis Pirmettis, et al.
Antiviral Research|June 12, 2018
Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium modelBernadett Boda, Sacha Benaoudia, Song Huang, et al.
Pharmaceutical Research|April 27, 2016
Pharmacological Development of Target-Specific Delocalized Lipophilic Cation-Functionalized Carboranes for Cancer TherapyEirini D Tseligka, Aikaterini Rova, Elsa P Amanatiadou, et al.
Plos Pathogens|August 4, 2018
A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropismEirini D Tseligka, Komla Sobo, Luc Stoppini, et al.
Cell Reports|April 14, 2023
Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted miceKuo-Feng Weng, Han Kang Tee, Eirini D Tseligka, et al.
Scientific Reports|May 15, 2023
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistanceDiana Gomes, Cyril Sobolewski, Stéphanie Conzelmann, et al.
International Journal of Pharmaceutics|May 29, 2016
Biocompatible Zr-based nanoscale MOFs coated with modified poly(ε-caprolactone) as anticancer drug carriersMaria Filippousi, Stuart Turner, Karen Leus, et al.
Pageof 1